Hans J. W. de Haard
Corporate Officer/Principal chez University of Utrecht
Profil
Hans J.
W.
de Haard is the founder of AgomAb Therapeutics NV, which was founded in 2017.
He is also the founder of argenx SE, which was founded in 2008.
At argenx SE, he held the title of Chief Scientific Officer.
Dr. de Haard currently holds positions at the University of Utrecht as a Professor-Camelid Immunology since 2012, and at Université de Franche-Comté as a Professor.
In his former positions, Dr. de Haard worked at Ablynx NV as a Senior Director-Discovery Research, and at Unilever NV as a Scientist.
Dr. de Haard obtained his graduate and doctorate degrees from Maastricht University.
Postes actifs de Hans J. W. de Haard
| Sociétés | Poste | Début |
|---|---|---|
| University of Utrecht | Corporate Officer/Principal | - |
| Université de Franche-Comté | Corporate Officer/Principal | - |
Anciens postes connus de Hans J. W. de Haard
| Sociétés | Poste | Fin |
|---|---|---|
AgomAb Therapeutics NV
 AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Founder | - |
| ARGENX SE | Founder | - |
| UNILEVER N.V. | Chief Tech/Sci/R&D Officer | - |
| ABLYNX | Chief Tech/Sci/R&D Officer | - |
Formation de Hans J. W. de Haard
| Maastricht University | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Entreprise privées | 3 |
|---|---|
Unilever NV
 Unilever NV Food DistributorsDistribution Services Unilever NV engages in the production and marketing of consumer goods in the nutrition, hygiene, and personal care categories. It operates through the following segments: Beauty and Personal Care, Foods and Refreshment, and Home Care. The Beauty and Personal Care segment covers the sales of skin and hair care products, deodorants and oral care products. The Foods and Refreshment segment includes the sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads. The Home Care segment is in charge of the sales of home care products such as powders, liquids and capsules, soap bars, and a wide range of cleaning products. The company was founded on November 9, 1927 and is headquartered in Rotterdam, Netherlands. | Distribution Services |
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |
